Green Jeremy
Transactions
50
Companies
35
Filings
5
CIK
0001650527
Recent Transactions
- Purchase
- Other
- Other
Class A Convertible Preferred Stock
2024-12-20$8.40/sh+116,261→ 2,755,086 total - Sale
- Other
Class A Convertible Preferred Stock
2024-12-20$8.40/sh−116,261→ 2,638,825 total - Other
- Other
- Conversion
- Conversion
- PurchaseADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-12-11$3.81/sh+50,000→ 15,666,731 total - PurchaseADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-12-11$2.28/sh+50,000→ 13,095,712 total - PurchaseADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-12-11$2.28/sh+50,000→ 15,616,731 total - PurchaseADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-12-11$3.81/sh+50,000→ 13,145,712 total - OtherADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-12-04$2.07/sh+50,672→ 13,045,712 total - OtherShattuck Labs, Inc.$STTK
Common Stock, par value $0.0001 per share
2024-12-04$1.25/sh−1,026,888→ 4,512,836 total - PurchaseShattuck Labs, Inc.$STTK
Common Stock, par value $0.0001 per share
2024-12-04$1.25/sh+133,371→ 5,539,724 total - Other
- SaleADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-12-04$2.07/sh−25,352→ 15,566,731 total - OtherADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-12-04$2.07/sh+50,672→ 15,566,731 total - Other
- Other
- OtherADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-12-04$2.07/sh−50,672→ 15,516,059 total - SaleShattuck Labs, Inc.$STTK
Common Stock, par value $0.0001 per share
2024-12-04$1.25/sh−133,371→ 5,406,353 total - OtherShattuck Labs, Inc.$STTK
Common Stock, par value $0.0001 per share
2024-12-04$1.25/sh+1,026,888→ 5,539,724 total - Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- PurchaseADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-07-01$2.81/sh+400,000→ 12,995,040 total - PurchaseADC Therapeutics SA$ADCT
Common Shares, par value CHF 0.08 per share
2024-07-01$2.81/sh+400,000→ 15,669,217 total - Award
- Award
- Award
- Award
- Award
- Award
- Purchase
- Purchase
- Award
- Other
- Other
- Award
Pre-Funded Warrants to Purchase Common Stock
2024-03-21$5.50/sh+3,636,364→ 3,893,674 total - Award
- Disposition from Tender
- Disposition to Issuer
- Disposition to Issuer
Companies
35- $ABSI
Absci Corp
Director, 10% Owner
- $ADCT
ADC Therapeutics SA
10% Owner
- $AKRO
Akero Therapeutics, Inc.
10% Owner
ALDER BIOPHARMACEUTICALS INC
Director
Allakos Inc.
10% Owner
- $ANNX
Annexon, Inc.
10% Owner
- $APRE
Aprea Therapeutics, Inc.
10% Owner
ARRAY BIOPHARMA INC
10% Owner
Atreca, Inc.
10% Owner
Augmedix, Inc.
Director, 10% Owner
- $BEAM
Beam Therapeutics Inc.
10% Owner
- $CABA
Cabaletta Bio, Inc.
10% Owner
- $TRDA
Entrada Therapeutics, Inc.
10% Owner
- $FATE
FATE THERAPEUTICS INC
Director, 10% Owner
Gritstone bio, Inc.
10% Owner
- $HOOK
HOOKIPA Pharma Inc.
10% Owner
IGM Biosciences, Inc.
Director, 10% Owner
- $IVVD
Invivyd, Inc.
10% Owner
- $KLRS
Kalaris Therapeutics, Inc.
10% Owner
- $KYMR
Kymera Therapeutics, Inc.
10% Owner
MedAvail Holdings, Inc.
Director, 10% Owner
- $NGNE
Neurogene Inc.
10% Owner
- $NRIX
Nurix Therapeutics, Inc.
10% Owner
- $PLRX
PLIANT THERAPEUTICS, INC.
10% Owner
RayzeBio, Inc.
10% Owner
- $RPTX
Repare Therapeutics Inc.
10% Owner
- $REPL
Replimune Group, Inc.
10% Owner
Science 37 Holdings, Inc.
Director, 10% Owner
- $STTK
Shattuck Labs, Inc.
Director, 10% Owner
- $STOK
Stoke Therapeutics, Inc.
10% Owner
TCR2 THERAPEUTICS INC.
10% Owner
VAPOTHERM INC
10% Owner
Verve Therapeutics, Inc.
10% Owner
XERIS PHARMACEUTICALS INC
10% Owner
- $ZYME
Zymeworks Inc.
10% Owner
Recent Filings
5Address
ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300
SAN FRANCISCO, CA, 94129